The Beatson Institute for Cancer Research in Bearsden, Scotland, and Carestream Molecular Imaging have signed a five-year partnership agreement to support the development of preclinical imaging approaches in oncology using the Carestream Albira trimodal imaging system.
The Massachusetts Life Sciences Center has awarded Boston’s Dana-Farber Cancer Institute a $10 million grant to support the expansion of its cancer imaging research program.
Molecular Imaging, a contract research organization (CRO) providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, has entered into a licensing agreement with Dana-Farber Cancer Institute in Boston to access a number of luciferase-enabled cancer cell lines developed at Dana-Farber.
ImaginAb has been awarded $2.3 million in funding from the National Cancer Institute's (NCI) Small Business Innovation Research program to help further develop diagnostic imaging agents for PET.
Carestream Molecular Imaging has added the In-Vivo Xtreme to its family of multimodal imaging products for preclinical research. Xtreme will be introduced at the World Molecular Imaging Congress Sept 7-10 in San Diego.
Eckert & Ziegler, a German-based isotope company, has acquired the radiopharmaceutical equipment business of Washington, D.C.-based Bioscan.
Researchers at Fred Hutchinson Cancer Research Center in Seattle have demonstrated in mice that the performance of a novel biomarker-development pipeline using targeted mass spectrometry is robust enough to support the use of an analogous approach in humans, based on findings by principal investigator Amanda Paulovich, MD, PhD, an associate member of the Hutchinson Center's clinical research division, and colleagues published in Nature Biotechnology.
RSS 
